Verrica Pharmaceuticals Inc
NASDAQ:VRCA

Watchlist Manager
Verrica Pharmaceuticals Inc Logo
Verrica Pharmaceuticals Inc
NASDAQ:VRCA
Watchlist
Price: 8.16 USD -2.04% Market Closed
Market Cap: 77.4m USD

Intrinsic Value

The intrinsic value of one VRCA stock under the Base Case scenario is hidden USD. Compared to the current market price of 8.16 USD, Verrica Pharmaceuticals Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

VRCA Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Verrica Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

VRCA looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if VRCA is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about VRCA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is VRCA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Verrica Pharmaceuticals Inc.

Explain Valuation
Compare VRCA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VRCA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Verrica Pharmaceuticals Inc

Current Assets 36.3m
Cash & Short-Term Investments 21.1m
Receivables 7.3m
Other Current Assets 7.8m
Non-Current Assets 4.6m
PP&E 1.9m
Other Non-Current Assets 2.7m
Current Liabilities 28.9m
Accounts Payable 1.6m
Accrued Liabilities 12.8m
Other Current Liabilities 14.5m
Non-Current Liabilities 29m
Long-Term Debt 22.2m
Other Non-Current Liabilities 6.8m
Efficiency

Free Cash Flow Analysis
Verrica Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Verrica Pharmaceuticals Inc

Revenue
30.8m USD
Cost of Revenue
-2.7m USD
Gross Profit
28.2m USD
Operating Expenses
-44.6m USD
Operating Income
-16.4m USD
Other Expenses
-9.6m USD
Net Income
-26m USD
Fundamental Scores

VRCA Profitability Score
Profitability Due Diligence

Verrica Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Verrica Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

VRCA Solvency Score
Solvency Due Diligence

Verrica Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Positive Net Debt
Short-Term Solvency
Long-Term Solvency
hidden
Solvency
Score

Verrica Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VRCA Price Targets Summary
Verrica Pharmaceuticals Inc

Wall Street analysts forecast VRCA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VRCA is 16.83 USD with a low forecast of 10.1 USD and a high forecast of 21 USD.

Lowest
Price Target
10.1 USD
24% Upside
Average
Price Target
16.83 USD
106% Upside
Highest
Price Target
21 USD
157% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Verrica Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for VRCA is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

VRCA Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one VRCA stock?

The intrinsic value of one VRCA stock under the Base Case scenario is hidden USD.

Is VRCA stock undervalued or overvalued?

Compared to the current market price of 8.16 USD, Verrica Pharmaceuticals Inc is hidden .

Back to Top